AAAAAA
Results: 26-50/792
Authors:
VELANOVICH V
Citation: V. Velanovich, FRACTAL ANALYSIS OF MAMMOGRAPHIC LESIONS - A PROSPECTIVE, BLINDED TRIAL, Breast cancer research and treatment, 49(3), 1998, pp. 245-249
Authors:
XU JM
SONG ST
TANG ZH
LIU XQ
JIANG ZF
ZHOU L
LI YB
HUANG K
Citation: Jm. Xu et al., EVALUATION OF IN-VITRO CHEMOSENSITIVITY OF ANTITUMOR DRUGS USING THE MTT ASSAY IN FRESH HUMAN BREAST-CANCER, Breast cancer research and treatment, 49(3), 1998, pp. 251-259
Authors:
BREUER B
SMITH S
THOR A
EDGERTON S
OSBORNE MP
MINICK R
CODY HS
NOWAK E
CORTESE A
SIMMONS RM
CARNEY WP
BRANDTRAUF PW
Citation: B. Breuer et al., ERBB-2 PROTEIN IN SERA AND TUMORS OF BREAST-CANCER PATIENTS, Breast cancer research and treatment, 49(3), 1998, pp. 261-270
Authors:
WHITTALSTRANGE KS
CHADAU S
PARKHOUSE WS
Citation: Ks. Whittalstrange et al., EXERCISE DURING PUBERTY AND NMU INDUCED MAMMARY TUMORIGENESIS IN RATS(VOL 47, PG 1, 1998), Breast cancer research and treatment, 49(2), 1998, pp. 1-1
Authors:
SRIVASTAVA RK
SRIVASTAVA AR
PARK YG
AGRAWAL S
CHOCHUNG YS
Citation: Rk. Srivastava et al., ANTISENSE DEPLETION OF RI-ALPHA SUBUNIT OF PROTEIN-KINASE-A INDUCES APOPTOSIS AND GROWTH ARREST IN HUMAN BREAST-CANCER CELLS, Breast cancer research and treatment, 49(2), 1998, pp. 97-107
Authors:
ELETREBY MF
LIANG YY
Citation: Mf. Eletreby et Yy. Liang, EFFECT OF ANTIPROGESTINS AND TAMOXIFEN ON GROWTH-INHIBITION OF MCF-7 HUMAN BREAST-CANCER CELLS IN NUDE-MICE, Breast cancer research and treatment, 49(2), 1998, pp. 109-117
Authors:
STEVENSON LE
FRACKELTON AR
Citation: Le. Stevenson et Ar. Frackelton, CONSTITUTIVELY TYROSINE-PHOSPHORYLATED P52 SHC IN BREAST-CANCER CELLS- CORRELATION WITH ERBB2 AND P66 SHC EXPRESSION, Breast cancer research and treatment, 49(2), 1998, pp. 119-128
Authors:
BALDINI E
TIBALDI C
CHIAVACCI F
DILIETO M
FIORETTO L
GIALLOMBARDO A
TAVIANI R
GHEZZI P
BOLOGNINI A
CONTE P
Citation: E. Baldini et al., EPIRUBICIN VINORELBINE AS FIRST LINE THERAPY IN METASTATIC BREAST-CANCER/, Breast cancer research and treatment, 49(2), 1998, pp. 129-134
Authors:
DESCOTES F
VILLE G
BOBIN JY
BARBIER Y
SAEZ S
Citation: F. Descotes et al., TISSUE EXTRACTION PROCEDURES FOR INVESTIGATION OF UROKINASE PLASMINOGEN-ACTIVATOR (UPA) AND ITS INHIBITORS PAI-1 AND PAI-2 IN HUMAN BREAST CARCINOMAS, Breast cancer research and treatment, 49(2), 1998, pp. 135-143
Authors:
SOLOMAYER EF
DIEL IJ
MEYBERG GC
GOLLAN C
BODE S
WALLWIENER D
BASTERT G
Citation: Ef. Solomayer et al., PROGNOSTIC RELEVANCE OF CATHEPSIN-D DETECTION IN MICROMETASTATIC CELLS IN THE BONE-MARROW OF PATIENTS WITH PRIMARY BREAST-CANCER, Breast cancer research and treatment, 49(2), 1998, pp. 145-154
Authors:
GOODSON WH
MOORE DH
LJUNG BM
CHEW K
FLORENDO C
MAYALL B
SMITH HS
WALDMAN FM
Citation: Wh. Goodson et al., THE FUNCTIONAL-RELATIONSHIP BETWEEN IN-VIVO BROMODEOXYURIDINE LABELING INDEX AND KI-67 PROLIFERATION INDEX IN HUMAN BREAST-CANCER, Breast cancer research and treatment, 49(2), 1998, pp. 155-164
THE INCIDENCE OF MICROSATELLITE INSTABILITY AND LOSS OF HETEROZYGOSITY IN FIBROADENOMA OF THE BREAST
Authors:
MCCULLOCH RK
SELLNER LN
PAPADIMITROU JM
TURBETT GR
Citation: Rk. Mcculloch et al., THE INCIDENCE OF MICROSATELLITE INSTABILITY AND LOSS OF HETEROZYGOSITY IN FIBROADENOMA OF THE BREAST, Breast cancer research and treatment, 49(2), 1998, pp. 165-169
Authors:
NANGIAMAKKER P
SARVIS R
VISSCHER DW
BAILEYPENROD J
RAZ A
SARKAR FH
Citation: P. Nangiamakker et al., GALECTIN-3 AND L1 RETROTRANSPOSONS IN HUMAN BREAST CARCINOMAS, Breast cancer research and treatment, 49(2), 1998, pp. 171-183
Authors:
LUO SQ
LABRIE C
BELANGER A
CANDAS B
LABRIE F
Citation: Sq. Luo et al., PREVENTION OF DEVELOPMENT OF DIMETHYLBENZ(A)ANTHRACENE (DMBA)-INDUCEDMAMMARY-TUMORS IN THE RAT BY THE NEW NONSTEROIDAL ANTIESTROGEN EM-800(SCH57050), Breast cancer research and treatment, 49(1), 1998, pp. 1-11
Authors:
FRASCI G
COMELLA P
DAIUTO G
BUDILLON A
BARBARULO D
THOMAS R
CAPASSO I
CASARETTI R
DAPONTE A
CAPONIGRO F
GRAVINA A
MAIORINO L
CARATENI G
GENTILE A
COMELLA G
Citation: G. Frasci et al., WEEKLY PACLITAXEL-CISPLATIN ADMINISTRATION WITH G-CSF SUPPORT IN ADVANCED BREAST-CANCER - A PHASE-II STUDY, Breast cancer research and treatment, 49(1), 1998, pp. 13-26
Authors:
LANDYS K
PERSSON S
KOVARIK J
HULTBORN R
HOLMBERG E
Citation: K. Landys et al., PROGNOSTIC VALUE OF BONE-MARROW BIOPSY IN OPERABLE BREAST-CANCER PATIENTS AT THE TIME OF INITIAL DIAGNOSIS - RESULTS OF A 20-YEAR MEDIAN FOLLOW-UP, Breast cancer research and treatment, 49(1), 1998, pp. 27-33
Authors:
PRATAP R
SHOUSHA S
Citation: R. Pratap et S. Shousha, BREAST-CARCINOMA IN WOMEN UNDER THE AGE OF 50 - RELATIONSHIP BETWEEN P53 IMMUNOSTAINING, TUMOR GRADE, AND AXILLARY LYMPH-NODE STATUS, Breast cancer research and treatment, 49(1), 1998, pp. 35-39
Authors:
CHUNG HC
RHA SY
PARK JO
YOO NC
KIM JH
ROH JK
MIN JS
LEE KS
KIM BS
KIM JJ
Citation: Hc. Chung et al., PHYSIOLOGICAL AND PATHOLOGICAL-CHANGES OF PLASMA UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND UROKINASE-TYPEPLASMINOGEN-ACTIVATOR RECEPTOR LEVELS IN HEALTHY FEMALES AND BREAST-CANCER PATIENTS, Breast cancer research and treatment, 49(1), 1998, pp. 41-50
Authors:
NOMURA Y
SHIROUZU M
TAKAYAMA T
Citation: Y. Nomura et al., DIRECT COMPARISONS OF ADJUVANT ENDOCRINE THERAPY, CHEMOTHERAPY, AND CHEMOENDOCRINE THERAPY FOR OPERABLE BREAST-CANCER PATIENTS STRATIFIED BY ESTROGEN-RECEPTOR AND MENOPAUSAL STATUS, Breast cancer research and treatment, 49(1), 1998, pp. 51-60
Authors:
BRANDES LJ
BRACKEN SP
Citation: Lj. Brandes et Sp. Bracken, THE INTRACELLULAR HISTAMINE ANTAGONIST, DIETHYL-2-[4-(PHENYLMETHYL)PHENOXY]ETHANAMINE.HCL, MAY POTENTIATE DOXORUBICIN IN THE TREATMENT OF METASTATIC BREAST-CANCER - RESULTS OF A PILOT-STUDY, Breast cancer research and treatment, 49(1), 1998, pp. 61-68
Authors:
DALBERG K
MATTSSON A
SANDELIN K
RUTQVIST LE
Citation: K. Dalberg et al., OUTCOME OF TREATMENT FOR IPSILATERAL BREAST-TUMOR RECURRENCE IN EARLY-STAGE BREAST-CANCER, Breast cancer research and treatment, 49(1), 1998, pp. 69-78
Authors:
AKASHITANAKA S
FUKUTOMI T
MIYAKAWA K
UCHIYAMA N
TSUDA H
Citation: S. Akashitanaka et al., DIAGNOSTIC-VALUE OF CONTRAST-ENHANCED COMPUTED-TOMOGRAPHY FOR DIAGNOSING THE INTRADUCTAL COMPONENT OF BREAST-CANCER, Breast cancer research and treatment, 49(1), 1998, pp. 79-86
Authors:
SCHULGEN G
SCHMOOR C
SAUERBREI W
SCHUMACHER M
Citation: G. Schulgen et al., A NOTE ON ESTIMATING LOCAL RECURRENCE RATES IN CLINICAL-TRIALS ON THETREATMENT OF BREAST-CANCER, Breast cancer research and treatment, 49(1), 1998, pp. 87-91
Authors:
WEI W
SANTNER SJ
MASAMURA S
WANG JP
DEMERS LM
HAMILTON C
SANTEN RJ
Citation: W. Wei et al., DETERMINANTS OF TISSUE ESTRADIOL LEVELS AND BIOLOGIC RESPONSIVENESS IN BREAST-TUMORS, Breast cancer research and treatment, 49, 1998, pp. 1-7
Authors:
SINGH A
PUROHIT A
COLDHAM NG
GHILCHIK MW
REED MJ
Citation: A. Singh et al., BIOCHEMICAL CONTROL OF BREAST AROMATASE, Breast cancer research and treatment, 49, 1998, pp. 9-14